Mirabegron

Product NDC
70771-1753
11-digit product format
707711753
Labeler code
70771
Product ID
70771-1753_6ad07423-8166-4871-81cd-c1e6449410e6
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Mirabegron
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Labeler
Zydus Lifesciences Limited
Application
ANDA209488
Marketing category
ANDA
Marketing start
2024-01-23
Substance
MIRABEGRON
Active strength
50 mg/1
Pharmacologic classes
Adrenergic beta3-Agonists [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], beta3-Adrenergic Agonist [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Mirabegron
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
MIRABEGRON50 mg/1

Harmonized Identifiers#

Field, Values table
FieldValues
UniiMVR3JL3B2V
Rxcui1300791, 1300801

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
c73f394f-7cf1-bcd8-df99-a95ef4373ff6Product name420250116

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
70771-1753-12024-03-06C16284748780-11030e365-3d0c-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use MIRABEGRON EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MIRABEGRON EXTENDED-RELEASE TABLETS MIRABEGRON extended-release tablets, for oral use Initial U.S. Approval: 2012
70771-1753-32024-03-06C16284748780-11030e365-3d0c-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use MIRABEGRON EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MIRABEGRON EXTENDED-RELEASE TABLETS MIRABEGRON extended-release tablets, for oral use Initial U.S. Approval: 2012
70771-1753-92024-03-06C16284748780-11030e365-3d0c-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use MIRABEGRON EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MIRABEGRON EXTENDED-RELEASE TABLETS MIRABEGRON extended-release tablets, for oral use Initial U.S. Approval: 2012
70771-1753-12024-01-30C16284748780-11030e365-3d0c-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use MIRABEGRON EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MIRABEGRON EXTENDED-RELEASE TABLETS MIRABEGRON extended-release tablets, for oral use Initial U.S. Approval: 2012
70771-1753-32024-01-30C16284748780-11030e365-3d0c-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use MIRABEGRON EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MIRABEGRON EXTENDED-RELEASE TABLETS MIRABEGRON extended-release tablets, for oral use Initial U.S. Approval: 2012
70771-1753-92024-01-30C16284748780-11030e365-3d0c-111a-e063-dadaa90a10e2These highlights do not include all the information needed to use MIRABEGRON EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for MIRABEGRON EXTENDED-RELEASE TABLETS MIRABEGRON extended-release tablets, for oral use Initial U.S. Approval: 2012

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
70771-1753-1Mirabegron100 in 1 BOTTLETABLET, EXTENDED RELEASE1003
70771-1753-3Mirabegron30 in 1 BOTTLETABLET, EXTENDED RELEASE303
70771-1753-9Mirabegron90 in 1 BOTTLETABLET, EXTENDED RELEASE903

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
70771-1753MIRABEGRON TABLET, EXTENDED RELEASE [ZYDUS LIFESCIENCES LIMITED]3Current NDC, 3 package rows20241013_461b2b94-205a-4860-9cb4-d30267ada9df.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1300791mirabegron 25 MG 24HR Extended Release Oral TabletPSN461b2b94-205a-4860-9cb4-d30267ada9df3
1300801mirabegron 50 MG 24HR Extended Release Oral TabletPSN461b2b94-205a-4860-9cb4-d30267ada9df3
130079124 HR mirabegron 25 MG Extended Release Oral TabletSCD461b2b94-205a-4860-9cb4-d30267ada9df3
130080124 HR mirabegron 50 MG Extended Release Oral TabletSCD461b2b94-205a-4860-9cb4-d30267ada9df3
1300791mirabegron 25 MG 24 HR Release TabletSY461b2b94-205a-4860-9cb4-d30267ada9df3
1300801mirabegron 50 MG 24 HR Extended Release Oral TabletSY461b2b94-205a-4860-9cb4-d30267ada9df3

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
70771-1753-170771175301100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1753-1) 2024-01-23NoNoHistorical
70771-1753-37077117530330 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1753-3) 2024-01-23NoNoHistorical
70771-1753-97077117530990 TABLET, EXTENDED RELEASE in 1 BOTTLE (70771-1753-9) 2024-01-23NoNoHistorical